By Market Intelligence Team

The Oklahoma Medicaid program and Pear Therapeutics entered a value-based access agreement for Pear’s reSET and reSET-O prescription digital therapeutic (PDT) addiction treatments. The agreement went into effect on January 1, 2022, for beneficiaries enrolled in the Oklahoma Health Care Authority (OHCA) SoonerCare program. OHCA has not disclosed the specific performance and outcomes-based benchmarks being monitored under this agreement, or the terms of payment. The agreement leverages the Oklahoma State Medicaid plan amendment to implement voluntary Medicaid value-based drug purchasing agreements. About 44% of the 1.2 million people are enrolled in SoonerCare are over age 21. The reSET PDT is…